Quarterly report [Sections 13 or 15(d)]

Balance Sheet Components

v3.25.1
Balance Sheet Components
 3 Months Ended
Mar. 31, 2025
Balance Sheet Components [Abstract]  
Balance Sheet Components

4. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2024 and March 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2024     2025  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 263       137  
Prepaid drug manufacturing supply costs     3,572       6,072  
Other     971       1,368  
Total   $ 4,806       7,577  

 

Property, plant and equipment as of December 31, 2024 and March 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2024     2025  
             
Leasehold improvements   $         49     $         49  
Lab equipment     26       26  
Furniture and fixtures     39       55  
Subtotal     114       130  
Less accumulated depreciation     (39 )     (47 )
Net   $ 75       83  

 

Accounts payable as of December 31, 2024 and March 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2024     2025  
             
Trade accounts payable   $ 966       1,251  
Credit card liability     92       146  
Total   $ 1,058       1,397  

 

Accrued liabilities as of December 31, 2024 and March 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2024     2025  
             
Accrued labor costs   $ 1,910     $ 2,372  
Accrued drug development costs     1,258       959  
Other     394       812  
Total   $ 3,562     $ 4,143